| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 31, 2006
Accepted on August 25, 2006
HYDROXYSTEROID DEHYDROGENASE IN HUMAN GRANULOSA-LUTEIN CELLS
Department of Biochemistry and Molecular Biology, Royal Free and University College Medical School, University College London, Gower Street, London, WC1E 6BT, UK; Department of Veterinary Basic Science, Royal Veterinary College, Royal College Street, London, NW1 0TU, UK; Centre for Developmental and Endocrine Signalling, Academic Section of Obstetrics & Gynaecology, Division of Clinical Developmental Sciences, St.George's, University of London, Cranmer Terrace, London SW17 0RE, UK
* To whom correspondence should be addressed. E-mail: kjonas{at}rvc.ac.uk.
11
-hydroxysteroid dehydrogenase (11
HSD) enzymes regulate glucocorticoid availability in target tissues. 11
HSD1 is the predominant isoenzyme expressed and active in human granulosa-lutein (hGL) cells. This study investigated the effects of pharmacological inhibitors of prostaglandin (PG) synthesis on 11
HSD1 activities and expression in hGL cells. The consequences for 11
HSD1 of increasing exposure of hGL cells to PGs, either by treatment with exogenous PGs or by challenging cells with interleukin-1
(IL-1
), were also assessed. Suppression of basal PG synthesis using 4 different inhibitors of prostaglandin H synthase enzymes (indomethacin, niflumic acid, meclofenamic acid (MA) and N-(2-cyclohexyloxy-4-nitorophenyl) methane sulfonamide (NS-398)) each resulted in significant decreases in both cortisol oxidation and cortisone reduction. Both activities of 11
HSD1 were suppressed by up to 64 ± 6% (P < 0.05). Over 4 and 24 h, neither MA nor NS-398 affected the expression of 11
HSD1 protein, suggesting enzyme regulation by PGs at the post-translational level. When cells were co-treated for 4 h with PGHS inhibitors plus 30 nM PGD2, PGF2
or PGE2, each PG overcame the suppression of cortisol oxidation by indomethacin or MA. Treatment of hGL cells with IL-1
increased the concentrations of both PGE2 and PGF2
, accompanied by a 70 ± 25% increase in net cortisol oxidation. All 3 responses to IL-1
were abolished when cells were co-treated with MA. These findings suggest a role for prostaglandins in the post-translational regulation of 11
HSD1 activities in hGL cells.
This article has been cited by other articles:
![]() |
J. Komiyama, R. Nishimura, H.-Y. Lee, R. Sakumoto, M. Tetsuka, T. J. Acosta, D. J. Skarzynski, and K. Okuda Cortisol Is a Suppressor of Apoptosis in Bovine Corpus Luteum Biol Reprod, May 1, 2008; 78(5): 888 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
K S Fegan, M T Rae, H O D Critchley, and S G Hillier Anti-inflammatory steroid signalling in the human peritoneum J. Endocrinol., February 1, 2008; 196(2): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Myers, M. C. Lamont, S. van den Driesche, N. Mary, K. J. Thong, S. G. Hillier, and W. C. Duncan Role of Luteal Glucocorticoid Metabolism during Maternal Recognition of Pregnancy in Women Endocrinology, December 1, 2007; 148(12): 5769 - 5779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Chandras, T E Harris, A L. Bernal, D R E Abayasekara, and A E Michael PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11{beta}-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa lutein cells J. Endocrinol., September 1, 2007; 194(3): 595 - 602. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |